6th Annual Clinical Research in Emerging Countries
July 27-29, 2011
This conference comes at a pivotal time for the life science industry. The benefits of performing trials in emerging markets such as Latin America, Asia Pacific Region and Eastern Europe include lowering overall cost of trial, faster timelines, and increased patient populations. As globalization becomes the industry norm, and more trials require naïve patient populations, trials in the ‘pharmerging’ countries will continue to flourish.
Continuing our renown clinical trials series, our 6th Annual Clinical Research in Emerging Countries Conference will continue to deliver what it has done best in the past, case study presentations from leading experts from the top emerging markets and provide strategies and knowledge on critical issues such as: optimizing global clinical trials, regulatory and legal compliance, training of personnel, overcoming cultural barriers, and clinical outsourcing opportunities.
However, with a new installment in the series comes current and critical discussion topics that will center on the clinical aspects and operations included in clinical research in emerging markets: translation challenges, the design of clinical studies, logistics, patient recruitment and retention, orphan/niche drug therapies, and site selection.
Also covered, will be the quality of the data. New regional regulatory mandates to be covered include: Mexico and Russia. Each has issued new regulatory mandates that impact the performance of clinical trials.
marcus evans invites senior level executives from leading (bio) pharmaceutical and medical device organizations with responsibilities or involvement in the following areas:
Global Clinical Affairs /Regional Clinical Affairs
For additional information email David Drey: firstname.lastname@example.org or call 312-540-3000 x6583.